30th Jun 2011 7:00 am |
RNS |
Second Phase III Pain Trial Commences |
8th Jun 2011 5:01 pm |
RNS |
Director/PDMR Shareholding |
8th Jun 2011 3:01 pm |
RNS |
Director/PDMR Shareholding |
8th Jun 2011 7:00 am |
RNS |
Regulatory Approval |
3rd Jun 2011 11:00 am |
RNS |
Director/PDMR Shareholding |
26th May 2011 7:00 am |
RNS |
Regulatory Approval |
18th May 2011 1:14 pm |
RNS |
Blocklisting Application |
17th May 2011 7:00 am |
RNS |
Half Yearly Report |
28th Apr 2011 7:00 am |
RNS |
Notice of Results - Amendment |
27th Apr 2011 5:59 pm |
RNS |
Notice of Results |
20th Apr 2011 7:00 am |
RNS |
US Patent Granted for Sativex in Cancer Pain |
15th Apr 2011 7:00 am |
RNS |
Regulatory Approval |
11th Apr 2011 7:00 am |
RNS |
Exclusive Licence Agreement Signed with Novartis |
25th Mar 2011 4:40 pm |
RNS |
Second Price Monitoring Extn |
25th Mar 2011 4:35 pm |
RNS |
Price Monitoring Extension |
25th Mar 2011 4:15 pm |
RNS |
Director/PDMR Shareholding |
22nd Mar 2011 7:00 am |
RNS |
Sativex Mutual Recognition Procedure Closes |
15th Mar 2011 4:40 pm |
RNS |
Second Price Monitoring Extn |
15th Mar 2011 4:35 pm |
RNS |
Price Monitoring Extension |
14th Mar 2011 7:00 am |
RNS |
Sativex launched in Spain |
2nd Mar 2011 7:00 am |
RNS |
Positive Sativex Study in MS Spasticity Published |
22nd Feb 2011 8:23 am |
RNS |
Holding(s) in Company |
17th Feb 2011 5:47 pm |
RNS |
Blocklisting Application |
17th Feb 2011 5:46 pm |
RNS |
Blocklisting Interim Review |
17th Feb 2011 5:42 pm |
RNS |
Issue of Equity |
17th Feb 2011 7:00 am |
RNS |
Sativex granted reimbursement in Spain |
9th Feb 2011 10:25 am |
RNS |
Director/PDMR Shareholding |
19th Jan 2011 5:05 pm |
RNS |
AGM Resolutions passed |
17th Jan 2011 7:00 am |
RNS |
Receipt of Milestone Payment |
20th Dec 2010 9:29 am |
RNS |
Adviser - Change of Name |
13th Dec 2010 4:15 pm |
RNS |
Director/PDMR Shareholding |
9th Dec 2010 2:39 pm |
RNS |
Publication of Annual Report |
8th Dec 2010 3:52 pm |
RNS |
Director/PDMR Shareholding |
3rd Dec 2010 7:00 am |
RNS |
Change of Adviser |
29th Nov 2010 4:31 pm |
RNS |
Director/PDMR Shareholding |
23rd Nov 2010 7:01 am |
RNS |
Sativex Enters Phase III Cancer Pain Programme |
23rd Nov 2010 7:00 am |
RNS |
Final Results |
19th Nov 2010 10:10 am |
RNS |
Update on Nomad and Broker Position |
3rd Nov 2010 7:00 am |
RNS |
Sativex Approved in New Zealand for MS Spasticity |
21st Oct 2010 11:30 am |
RNS |
Notice of Results |